Glaukos (GKOS) Gains from Investment Securities (2013 - 2026)
Glaukos (GKOS) reported Gains from Investment Securities of $304000.0 for Q1 2026, down 93.73% year-over-year from $4.8 million in Q1 2025, and down 73.61% quarter-over-quarter from $1.2 million in Q4 2025.
Glaukos (GKOS) Gains from Investment Securities (2013 - 2026) Analysis & Trends
Glaukos (GKOS) has 14 years of Gains from Investment Securities data on file, last reported at $304000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $304000.0, down 93.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 184.44% YoY), and the FY2025 annual result was $536000.0, up 578.48% from the prior year.
- Gains from Investment Securities declined to $304000.0 in Q1 2026 per GKOS's latest filing, from $1.2 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $4.8 million in Q1 2025 and troughed at -$4.3 million in Q2 2025.
- A 5-year average of $211764.7 and a median of $438000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities soared 2437.14% in 2022, then tumbled 334.25% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$2.9 million in 2022, then surged by 170.89% to $2.1 million in 2023, then sank by 185.79% to -$1.8 million in 2024, then jumped by 165.34% to $1.2 million in 2025, then slumped by 73.61% to $304000.0 in 2026.
- Business Quant data shows GKOS's Gains from Investment Securities at $304000.0 in Q1 2026, $1.2 million in Q4 2025, and -$557000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | Glaukos | 7.08 Bn | 6.98 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 1.15 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Sep 30, 2025 | -557,000.00 |
| Sep 30, 2025 | -557,000.00 |
| Jun 30, 2025 | -4.32 Mn |
| Jun 30, 2025 | -4.32 Mn |
| Mar 31, 2025 | 4.85 Mn |
| Mar 31, 2025 | 4.85 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Mar 31, 2024 | 197,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Dec 31, 2023 | 2.06 Mn |
| Dec 31, 2023 | 2.06 Mn |